GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks rocket on metal rebound and equities jump
December 01, 2025 / www.canadianminingreport.com
Silver supply shortage continues
December 01, 2025 / www.canadianminingreport.com
Several new entrants to TSXV large gold, including producer Asante
November 24, 2025 / www.canadianminingreport.com
Gold stocks down on metal decline, equity market slide
November 24, 2025 / www.canadianminingreport.com
Largest gold producers see strong Q3/25 earnings
November 17, 2025 / www.canadianminingreport.com